CANCER MONOCLONAL ANTIBODIES MARKET

Cancer Monoclonal Antibodies Market

Globally, cancer is one of the leading causes of death, and accounted for almost 13% of total deaths in 2008. The cases of lung and breast cancers are expected to grow rapidly in the coming years. In order to treat the life-threatening disease more efficiently and with enhanced specificity, monoclonal antibodies have become the most widely used cancer therapy. As per the findings of our new research report, cancer monoclonal antibodies provide high specificity to treat tumors and several formats exist for the types of cancer monoclonal antibodies available.

According to “Cancer Monoclonal Antibodies Market to 2015”, cancer monoclonal antibodies have evolved greatly from the first time they were implemented, and have created a strong demand since then. In the recent time, some very important monoclonal antibodies, such as Yervoy (ipilimumab) have entered the market. Our study expects that these antibodies will consume the share of leading monoclonal antibody products in the coming years.

Read » Cancer Monoclonal Antibodies Market

Published 39 weeks 6 days ago – Made popular 39 weeks 5 days ago
Category: Health | Tags:

Health

Login or register to post comments

Stories similar to Cancer Monoclonal Antibodies Market:

Additional information on Cancer Monoclonal Antibodies Market :
- Jan 3, 2013 ... Monoclonal antibodies market dominated by Remicade and Avastin ... of cancer, along with the increasing use of monoclonal antibodies in the ...
- Jun 14, 2010 ... Our new report - Monoclonal Antibodies in Cancer Therapy: World Market Prospects 2010-2025 - explains how this market will develop, and ...
- Anti-cancer monoclonal antibodies can be targeted against malignant cells by .... The current “big 5” therapeutic antibodies on the market are bevacizumab, ...
- Monoclonal antibody-based treatment of cancer has been established as one of ... voluntarily withdrawn in June 2010 following a post-marketing phase III trial), ...
- One of the key factors contributing to this market growth is the increasing prevalence of cancer. The Global Monoclonal Antibodies market has also been ...
- (PRBuzz. com) February 20, 2013 -- ResearchMoz. us include new market research report' Cancer Monoclonal Antibody Partnering Terms and Agreements' to ...
- Cancer Monoclonal Antibodies Market to 2015, Globally, cancer is one of the leading causes of death, and accounted for almost 13% of total deaths in 2008.
- Monoclonal antibody drugs — How monoclonal antibodies are being used in cancer treatment.

Related links about Cancer Monoclonal Antibodies Market :
1. Cancer Monoclonal Antibodies Market to 2015 - market research ...
2. Monoclonal antibody therapy - Wikipedia, the free encyclopedia
3. Latest Research: Cancer Monoclonal Antibody Partnering Terms ...
4. Research and Markets: Global Monoclonal Antibodies Market 2011 ...
5. Monoclonal antibodies in cancer therapy | Cancer Immunity

Cancer Monoclonal Antibodies Market Forecast to 2017 3 hours 35 min ago

Cancer, one of the leading causes of death worldwide, affected approximately 13 Million people in 2012 and this figure is expected to grow to 17 Million by 2020. The dramatic increase in the size of the potential cancer market has prompted pharmaceutical players to invest in the oncology sector with major focus on monoclonal antibodies.....

Global Monoclonal Antibody Market Analysis 2 years 50 weeks ago

Considered as an indispensable tool in the clinical and biotechnology sector, monoclonal antibodies have testified to be useful in the diagnosis and treatment of many infectious, immune, and neoplastic diseases along with its application in the study of pathogen-host interactions and dialing, detection, & quantification of different molecules.The presence of monoclonal antibodies therapeutics has changed the face of modern medicine in the past decade as they provide innovative and effective therapies for numerous previously refractory illnesses.

Future of Monoclonal Antibodies - Market Forecasts to 2015 3 years 47 weeks ago

GBI Research, the leading business intelligence provider, has released its latest research “The Future of Monoclonal Antibodies - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis.” The report provides in-depth analysis of unmet needs, drivers and barriers that impact the global monoclonal antibodies market. The report analyzes the markets for monoclonal antibodies in the US, the top five countries in Europe (the UK, Germany, France, Italy and Spain) and Japan.

Therapeutic Monoclonal Antibodies Market 38 weeks 4 days ago

How will the market for monoclonal antibody (mAb) therapies perform from 2011? Visiongain's report shows you potential revenues to 2021. Find opportunities and prospects.

How will competition affect the mAb industry and market? Which national markets have the greatest potential for growth? You can find predictions and explanations in this study. It covers cancer, autoimmune diseases and other applications for therapeutic mAbs.

Is monoclonal gammopathy related to cancer? 2 years 42 weeks ago

Monoclonal gammopathy of undetermined significance (MGUS) is a noncancerous condition. However, it may increase the risk of certain cancers, including multiple myeloma. The finding of monoclonal gammopathy on a blood test means that an abnormal protein (M protein) has been detected in your blood.